- Home
- ENSC vs BKYI Comparison
ENSC vs BKYI Comparison
Compare ENSC & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- BKYI
- Stock Information
- Founded
- ENSC 2003
- BKYI 1993
- Country
- ENSC United States
- BKYI United States
- Employees
- ENSC N/A
- BKYI N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- BKYI Computer Software: Prepackaged Software
- Sector
- ENSC Health Care
- BKYI Technology
- Exchange
- ENSC Nasdaq
- BKYI Nasdaq
- Market Cap
- ENSC 5.2M
- BKYI 4.8M
- IPO Year
- ENSC N/A
- BKYI 1997
- Fundamental
- Price
- ENSC $2.14
- BKYI $0.75
- Analyst Decision
- ENSC
- BKYI
- Analyst Count
- ENSC 0
- BKYI 0
- Target Price
- ENSC N/A
- BKYI N/A
- AVG Volume (30 Days)
- ENSC 84.6K
- BKYI 127.4K
- Earning Date
- ENSC 08-13-2025
- BKYI 08-13-2025
- Dividend Yield
- ENSC N/A
- BKYI N/A
- EPS Growth
- ENSC N/A
- BKYI N/A
- EPS
- ENSC N/A
- BKYI N/A
- Revenue
- ENSC $7,413,722.00
- BKYI $6,911,148.00
- Revenue This Year
- ENSC N/A
- BKYI $7.45
- Revenue Next Year
- ENSC $1,354.55
- BKYI $23.29
- P/E Ratio
- ENSC N/A
- BKYI N/A
- Revenue Growth
- ENSC 415.58
- BKYI N/A
- 52 Week Low
- ENSC $1.62
- BKYI $0.52
- 52 Week High
- ENSC $14.67
- BKYI $3.68
- Technical
- Relative Strength Index (RSI)
- ENSC 51.93
- BKYI 45.80
- Support Level
- ENSC $2.03
- BKYI $0.71
- Resistance Level
- ENSC $2.21
- BKYI $0.77
- Average True Range (ATR)
- ENSC 0.09
- BKYI 0.04
- MACD
- ENSC 0.01
- BKYI 0.00
- Stochastic Oscillator
- ENSC 63.38
- BKYI 32.46
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.